Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHVmutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI-Reference-Cited by-同舟云学术

Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHVmutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI

Published:2017-02-13 Issue:4 Volume:92 Page:375-380
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Delgado Julio¹,Doubek Michael²³,Baumann Tycho¹,Kotaskova Jana²³,Molica Stefano⁴,Mozas Pablo¹,Rivas-Delgado Alfredo¹,Morabito Fortunato⁵,Pospisilova Sarka²³,Montserrat Emili¹^ORCID

Affiliation:

1. Department of Hematology; Institute of Hematology and Oncology, Hospital Clínic, IDIBAPS, University of Barcelona; Barcelona Spain

2. Department of Internal Medicine - Hematology and Oncology; University Hospital Brno and Medical Faculty; Brno Czech Republic

3. Central European Institute of Technology (CEITEC), Masaryk University; Brno Czech Republic

4. Department Hematology-Oncology; Azienda Ospedaliera Pugliese-Ciaccio; Catanzaro Italy

5. UOC Ematologia, Azienda Ospedaliera di Cosenza; Cosenza Italy

Funder

Red Temática de Investigación Cooperativa en Cancer RT

Instituto de Salud Carlos III

ICGC-CLL Genome Project, Generalitat de Catalunya

“Emili Letang” (T.B.); Ministry of Health of the Czech Republic (The Czech team)

Ministry of Education, Youth and Sports of the Czech Republic project NPUII - CEITEC 2020

Publisher

Wiley

Subject

Hematology

Reference49 articles.

1. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines;Hallek;Blood.,2008

2. ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia;Ghia;Leukemia.,2007

3. Survival analysis in hematologic malignancies: Recommendations for clinicians;Delgado;Haematologica.,2014

4. The molecular pathogenesis of chronic lymphocytic leukaemia;Fabbri;Nat Rev Cancer.,2016

5. Clinical staging of chronic lymphocytic leukemia;Rai;Blood.,1975

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk scores predicting disease progression in early‐stage CLL: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy;Cancer;2024-09-12

2. What Prognostic Models Should We Use in CLL?;Clinical Lymphoma Myeloma and Leukemia;2024-09

3. It is feasible and safe to stop specialized follow-up of asymptomatic lower-risk chronic lymphocytic leukemia;Blood Advances;2024-08-27

4. Unmutated IGHV at diagnosis in patients with early stage CLL independently predicts for shorter follow-up time to first treatment (TTFT);Leukemia Research;2024-08

5. Spotlight on borderline-IGHV mutational status in chronic lymphocytic leukemia;Frontiers in Oncology;2024-06-06